Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007214 · ClinicalTrials.gov registry record · NA
Guided Biopsy for Mapping Prostate Cancer
A NA study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01007214: Clinical Trial NA study, sponsored by Roswell Park Cancer Institute.
NCT01007214 is a NA study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 7 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007214, a NA study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Evaluate the accuracy of HIT guided biopsies for mapping tumor foci with men undergoing prostatectomy.
Interventions
- PROCEDURE Prostatectomy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2010-05 |
| Est. Completion | 2014-02 |
| Phase | NA |
Why NCT01007214 stopped before completion
NCT01007214 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Prostatectomy is the first listed.
NCT01007214 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01007214 about?
NCT01007214 is a clinical study titled "Guided Biopsy for Mapping Prostate Cancer". Evaluate the accuracy of HIT guided biopsies for mapping tumor foci with men undergoing prostatectomy.
What is the current status of trial NCT01007214?
This trial is currently terminated. It is a NA study. The enrollment target is 7 participants. The study started on 2010-05. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01007214?
The interventions under investigation include: Prostatectomy (PROCEDURE).
Who is sponsoring clinical trial NCT01007214?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01007214's enrollment target sits among peer trials
7 1982nd of 2000 higher than 18 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia